A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury
Neurosurgical Review · 2024
DOI: 10.1007/s10143-024-02658-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neurosurgical Review, 2024. Verfasst von Shengdong Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Biomarkers, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: the Key Research and Development Projects of Zhejiang Province, The Zhejiang Provincial Medical and Health Science and Technology Plan.
Abstract (Originalsprache)
Receptor-interacting protein kinase-3 (RIP-3) is a key component for inducing necroptosis following acute brain injury. Purpose of this study is to unveil whether serum RIP-3 levels are related to severity and clinical outcomes after human severe traumatic brain injury (sTBI). In this two-center prospective cohort study, serum RIP-3 levels were detected in 127 healthy controls coupled with 127 sTBI patients. The prognostic indicators encompassed posttraumatic 180-day mortality, overall survival and poor prognosis (defined as extended Glasgow outcome scale scores of 1-4). The prognosis associations were verified via multivariate analysis. There was a significant incremental serum RIP-3 levels in patients with sTBI, relative to the controls. RIP-3 levels of patients were independently correlated with Rotterdam Computed Tomography (CT) scores and Glasgow coma scale (GCS) scores, as well as were independently predictive of mortality, overall survival and poor prognosis. Mortality and poor prognosis were effectively predicted by serum RIP-3 levels under the receiver operating characteristic curve. Linear relationships between RIP-3 levels and their risks were verified. Mortality and poor prognosis models of serum RIP-3 levels combined with GCS and Rotterdam CT scores displayed efficient predictive abilities. The two models were graphically represented, which were of clinical stability and value by employing the calibration and decision curves. Increased serum RIP-3 levels after sTBI are closely linked to heightened trauma severity and poor prognosis, signifying that serum RIP-3 may be an encouraging biomarker for evaluating severity and predicting clinical outcome of sTBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, China.
- Graduate School, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, China.
- Department of Neurosurgery, The Sixth Affiliated Hospital of Wenzhou Medical University, No. 15 Dazhong Road, Lishui, 323000, China.
- Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, No. 261 Huansha Road, Hangzhou, 310006, China.
- Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, No. 261 Huansha Road, Hangzhou, 310006, China. ljljcz2024@163.com.
Förderung
- the Key Research and Development Projects of Zhejiang Province
- The Zhejiang Provincial Medical and Health Science and Technology Plan
Zitieren
APA
Zou, S., Xu, J., Yang, W., Chen, Z., Shan, H., Liu, J., Tian, D., Wu, X., Du, Q., Dong, X., & Jiang, L. (2024). A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury. Neurosurgical Review. https://doi.org/10.1007/s10143-024-02658-9
Vancouver
Zou S, Xu J, Yang W, Chen Z, Shan H, Liu J, et al. A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury. Neurosurgical Review. 2024. doi:10.1007/s10143-024-02658-9
BibTeX
@article{Zou2024,
author = {Zou, Shengdong and Xu, Jian and Yang, Wenjie and Chen, Ziyin and Shan, Hao and Liu, Jin and Tian, Da and Wu, Xiaoyu and Du, Quan and Dong, Xiaoqiao and Jiang, Li},
title = {A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury},
journal = {Neurosurgical Review},
year = {2024},
doi = {10.1007/s10143-024-02658-9}
}
EUVIMED